![Morris Laster](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Morris Laster
Directeur Général chez
Clil Medical Ltd.
Profil
Morris C.
Laster is the founder of Xerem Medical Ltd. founded in 2015.
Dr. Laster was the founder of BioLineRx Ltd. founded in 2003 and served as Director from 2003 to 2009.
Dr. Laster was the founder of C.G.M.3 Ltd. founded in 2007 and served as Director from 2007 to 2011.
Dr. Laster was the founder of Purple Biotech Ltd. founded in 2011 and served as Chief Executive Officer from 2011 to 2014.
Dr. Laster is also the founder of Neose Technologies, Inc.,XTL Biopharmaceuticals Ltd...
Dr. Laster is Chief Executive Officer at Clil Medical Ltd. Dr. Laster is Director at Dynamix Pharmaceuticals Ltd. Dr. Laster is Director at HIL Applied Medical Ltd. Dr. Laster is Director at Nanolabz, Inc. Dr. Laster is Director at BrainQ Technologies Ltd. Dr. Laster is Director at DreaMed Diabetes Ltd. Dr. Laster is Medical Venture Partner at Ourcrowd Medtech Fund since 2013.
Dr. Laster was Chairman & Chief Executive Officer at Keryx Biopharmaceuticals, Inc. from 1997 to 2002.
Dr. Laster was Co-Chairman & Chief Executive Officer at Scopus Biopharma, Inc. from 2017 to 2021.
Dr. Laster was Independent Director at Scinai Immunotherapeutics Ltd. from 2017 to 2025.
Dr. Laster was Director at OncoHost Ltd. Dr. Laster was Managing Partner at OurCrowd Management Ltd. from 2013 to 2025.
Dr. Laster was Vice President-Medical Venture Capital at Paramount Capital Investments LLC in 1996.
Dr. Laster earned an undergraduate degree from State University of New York at Albany in 1986.
Dr. Laster earned a doctorate from State University of New York at Downstate Medical Center in 1990.
Postes actifs de Morris Laster
| Sociétés | Poste | Début |
|---|---|---|
Dynamix Pharmaceuticals Ltd.
 Dynamix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops small-molecule drugs for treating cancer and autoimmune disorders | Directeur/Membre du Conseil | 21/04/2010 |
HIL Applied Medical Ltd.
 HIL Applied Medical Ltd. Medical SpecialtiesHealth Technology Develops a technology system for cancer proton radiation therapy. | Directeur/Membre du Conseil | - |
Nanolabz, Inc.
 Nanolabz, Inc. Medical SpecialtiesHealth Technology Develops a technology system for cancer proton radiation therapy | Directeur/Membre du Conseil | - |
BrainQ Technologies Ltd.
 BrainQ Technologies Ltd. Packaged SoftwareTechnology Services Develops artificial intelligence-powered technologies to treat neuro-disorders | Directeur/Membre du Conseil | - |
Dreamed Diabetes Ltd.
 Dreamed Diabetes Ltd. Packaged SoftwareTechnology Services Develops software for diabetes treatment and management | Directeur/Membre du Conseil | - |
Ourcrowd Medtech Fund
 Ourcrowd Medtech Fund Investment ManagersFinance Functions as a venture capital fund | Corporate Officer/Principal | 01/07/2013 |
Clil Medical Ltd. | Directeur Général | - |
Anciens postes connus de Morris Laster
| Sociétés | Poste | Fin |
|---|---|---|
| BIONDVAX PHARMACEUTICALS LTD | Directeur/Membre du Conseil | 31/12/2025 |
OurCrowd Management Ltd.
 OurCrowd Management Ltd. Investment ManagersFinance OurCrowd invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital requirements. It makes follow on investments and also acts as a co-investor. | Private Equity Investor | 01/12/2025 |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░ | ░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Morris Laster
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
74
Relations au 1er degré
21
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 21 |
|---|---|
Neose Technologies, Inc.
 Neose Technologies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic protein drugs | Health Technology |
Keryx Biopharmaceuticals, Inc.
 Keryx Biopharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which focuses on therapies for patients with renal disease | Health Technology |
XTL Biopharmaceuticals Ltd.
 XTL Biopharmaceuticals Ltd. Medical SpecialtiesHealth Technology Develops pharmaceutical drugs for the treatment of autoimmune diseases | Health Technology |
State University of New York at Albany
 State University of New York at Albany Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioLineRx Ltd.
 BioLineRx Ltd. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company which develops and commercializes cell transplantation products | Health Technology |
State University of New York at Downstate Medical Center
 State University of New York at Downstate Medical Center Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Scinai Immunotherapeutics Ltd.
 Scinai Immunotherapeutics Ltd. Pharmaceuticals: OtherHealth Technology Operates as a biopharmaceutical company that develops, manufactures and commercializes immunomodulation therapies for infectious diseases | Health Technology |
Dynamix Pharmaceuticals Ltd.
Dynamix Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Discovers and develops small-molecule drugs for treating cancer and autoimmune disorders | Health Technology |
C.G.M.3 Ltd.
 C.G.M.3 Ltd. Medical SpecialtiesHealth Technology Develops a sensor containing implant to monitor glucose levels in diabetes patients | Health Technology |
Paramount Capital Investments LLC | |
OurCrowd Management Ltd.
OurCrowd Management Ltd. Investment ManagersFinance OurCrowd invests in companies located across the globe. The firm focuses on a broad range of sectors and industries. It provides financing for seed, early and later stage capital requirements. It makes follow on investments and also acts as a co-investor. | Finance |
Purple Biotech Ltd.
 Purple Biotech Ltd. Pharmaceuticals: MajorHealth Technology Provides pharmaceutical drug discovery and development services | Health Technology |
HIL Applied Medical Ltd.
HIL Applied Medical Ltd. Medical SpecialtiesHealth Technology Develops a technology system for cancer proton radiation therapy. | Health Technology |
Nanolabz, Inc.
Nanolabz, Inc. Medical SpecialtiesHealth Technology Develops a technology system for cancer proton radiation therapy | Health Technology |
Xerem Medical Ltd.
 Xerem Medical Ltd. Medical SpecialtiesHealth Technology Manufactures medical devices | Health Technology |
BrainQ Technologies Ltd.
BrainQ Technologies Ltd. Packaged SoftwareTechnology Services Develops artificial intelligence-powered technologies to treat neuro-disorders | Technology Services |
Scopus Biopharma, Inc.
 Scopus Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company develops transformational therapeutics for serious diseases | Health Technology |
Dreamed Diabetes Ltd.
Dreamed Diabetes Ltd. Packaged SoftwareTechnology Services Develops software for diabetes treatment and management | Technology Services |
Ourcrowd Medtech Fund
Ourcrowd Medtech Fund Investment ManagersFinance Functions as a venture capital fund | Finance |
OncoHost Ltd.
 OncoHost Ltd. Miscellaneous Commercial ServicesCommercial Services Develops cutting edge technology based therapeutics and cancer treatments | Commercial Services |
Clil Medical Ltd. |
